London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Kievsky
I've got enough for now - in fact sold a few to dabble in CNE.
Like everyone here getting frustrated with lack of news from IF et al. However, too much momentum is building for there not to be game changing news around the corner.... we mustn't forget we've only just had the key US patents granted.
I am particularly looking forward to an update on the US. Gixer, correct me if I am wrong but I do not think we have seen anything from North America this year. I am hoping we have given US/Canada exclusivity to someone.
(In profit from CNE already)
W$
Just topped up at less than 0.80. Think the mms are not expecting fireworks in our update. They may guess figures but it's the update from China I am really interested in. Don't see a need for a placing in the the next 10 months. W$, you going to top up at these prices
I am not sure whether IF will produce any new thing or not as he got used to good cut and paste. I think he need to look at VAL where two kicked out by the share holder like us. He is thinking very comfy position to take annual salary and no one bother to raise any comments about his performance. I am very sure there will be a time where people say enough is enough like VAL.
p.s.
Huilian Chen is linked to both the article and the study I posted the link to.
Alfista, Can't say for sure with this one but we know By-Health use Beijing Hospital, amongst others, for Fruitflow studies/trials as this link shows.
https://www.chictr.org.cn/showprojen.aspx?proj=56370
Chances are By-Health are behind this research article.
Fair amount of positive reviews and trials conducted in China now. Lets hope IF sees fit to give us a good update on what progress has been made in China in the upcoming results :)
Wonder if any of the study publishers are associated with By Health.
Yet more evidence that the scope of beneficial effects of Fruitflow continues to expand.
and lots of tiny trades !
FF is a good product from the consumers POV but from the money makers POV it isn't , they do not care about improving peoples health just making money and you can do that with any old thing with advertising. So they sell pills that cost 2p to make rather than 20p. In this respect Ian Ford is a sponge riding on the back of a pipe dream , as is the way of AIMs Co's. Evil Knevil was correct all those years ago when he was shorting PXS when it spiked. Having said that there maybe a miracle? Unlikely as like I have said before people don't think it will be them that gets sick so they don't bother with preventives.
Water-soluble tomato extract Fruitflow alters the phosphoproteomic profile of collagen-stimulated platelets
https://www.frontiersin.org/articles/10.3389/fphar.2021.746107/full
I thought the buck got passed to Buck.
Then we need new management.............problem is noone is accountable. The buck just gets passed to DSM. Not good enough for PIs
Fruitflow has always had enormous potential but if they cannot make a sales breakthrough during this period then====.
Completely disagree with delisting. Enormous potential in China with Bluehat status, together with our EFSA accreditation and the many gold standard studies. Transformation will begin after Bluehat and it's feasible Fruitflow will be an adjunct to other nutritionals and possibly drugs, such as Aspirin albeit hinges on a deal with major pharmaceutical due to cost of large scale studies. The product itself (Fruitflow) is gold standard. Spikey platelets cause so many health problems - blood pressure, blood flow, pollution toxicity, inflammation etc... We've got two out of 3 of the pillars of heart health - Blood pressure, Blood flow. I'm frustrated. In fact, very frustrated, but Bluehat in China in which we have a 1.4 billion population, Healthy China 2030, a prevention approach, high sports and natural supplement consciousness, and, I believe, biggest producer of tomatos in world. Plus, By-Health. Some years were wasted (agreed) not anymore. Plus FF smoothes platelets so Covid virus stands out more, meaning immune system can 'tag' the virus, attack and rid it from the human body.
What a load of cobs wallop. No guesses who recommended your post
Your thoughts mean nothing without valid reasoning behind them.
£50.00 by Christmas??
I know ill get shot down by most
But i think delisting is on the cards??
Super product, but expensive(maybe different with economy of scale)..Poor management and marketing skills coupled with death spiral loans that destroyed trust and confidence. Not forgetting the dreaded moon antics.
But you stayed silent for most of that time?
Y'right.
Two years ago it was sub .3.
Bad judgement Naz, you shoulda scooped some up shouldn't you.
I think this is an issue for many who have been here since Adam was a lad. Provexis maybe a good candidate for a seminar on how a super product failed to reach anything like its full potential. Perhaps this is due to poor leadership, the wrong partner and a chronic lack of funds for over a decade. For those who chose to see it (including the CEO at the time who found a way out) the company simply could not attract an end user of the calibre of Danone or Benecol as examples. However, the situation, grim as it is, could be better managed and updates given. I can't access the RNS service atm but I don't think there have been any updates at all this year. Is there really NOTHING at all to report and if so, what exactly is the CEO doing to manage this situation. Valid questions IMO.
Over the past 12 years;I have emailed DSM(when I was younger!) and thought "What a product "Surely having a Big backer in DSM What could possibly go wrong?,Response was We are working very hard to promote FRUITFLOW BLAH BLAH XX
I agree totally with you ,I fts been 11 years ,since its been below 1p
rhetorical question]
NOUN
a question asked in order to create a dramatic effect or to make a point rather than to get an answer.
Go on then.
Why are DSM unable to crack a sizeable one?Perhaps ask DSM?
A continual rise in the number of potential health claims for Fruitflow over the years ought to have been putting this in the minds of many more brands. There are so many now that perhaps the message is less than clear for which category to promote Fruitflow as being beneficial. Each claim, in order to be fully developed, could consume more resources. As every single one is a life enhancing benefit, it's hard to deny that such further development would be a good use of funds. Of all the brands we know about to date, only By Health have funded such further research. Against that, they are Chinese.
There should be more interest from Western brands, why are DSM seemingly unable to crack a sizeable one?